Human serums for early detection of ovarian cancer.

Developing Novel Tests for the Early Detection of Cancer

Abcodia is dedicated to transforming clinical care through the earlier detection of cancer. We focus on measuring and modeling dynamic changes in serum-based biomarkers over time. Our first product, the ROCA Test, is a blood test for the early detection of ovarian cancer.

Our Approach

Products & Pipelines

The ROCA Test

ROCA Test

The ROCA® Test is a simple blood test that helps determine a woman's risk of having ovarian cancer.

Learn More

Serum Biobank

Serum Biobank

Abcodia has exclusive commercial rights to a serum biobank that allows discovery and validation of biomarkers of early disease formation.

Learn More

Our Pipeline

Abcodia Pipeline

Abcodia is focused on the discovery and validation of non-invasive and cost effective blood tests for the earlier detection of solid tumors.

Learn More